Head-to-Head: which seizure drug works best for kids?

NCT ID NCT07163585

Completed Disease control Sponsor: RESnTEC, Institute of Research Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study compared two oral seizure medications, brivaracetam and levetiracetam, as first treatments in 102 children aged 1 month to 14 years with newly diagnosed epilepsy. Researchers looked at how well each drug stopped seizures and what side effects occurred. The goal is to help doctors choose the safest and most effective option for young patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: brivaracetam and levetiracetam (anti-seizure medications)
What this could lead to: If brivaracetam works as well or better with fewer side effects, it could become a preferred first-choice treatment for children with newly diagnosed epilepsy.
What could go wrong: This is a small, completed trial with 102 children, so results may not apply to all kids. Both drugs are already approved, so the main question is which is better tolerated, not a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Locations

The Children's Hospital and Institute of Child Health

Multan, Punjab Province, 66000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.